Literature DB >> 6281886

Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs.

F Labrie, R Veilleux, G Lefevre, D H Coy, J Sueiras-Diaz, A V Schally.   

Abstract

The presence of synthetic ovine corticotropin-releasing factor leads to a rapid and marked stimulation of adenosine 3', 5'-monophosphate accumulation in an enriched population of rat pituitary corticotrophs in primary culture. The increase, observed as early as 60 seconds after the addition of corticotropin-releasing factor, suggests that changes in the intracellular concentration of the cyclic nucleotide coincide with or precede the secretion of adrenocorticotropic hormone in response to corticotropin-releasing factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281886     DOI: 10.1126/science.6281886

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

1.  Corticotropin-releasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current.

Authors:  K Takano; J Yasufuku-Takano; A Teramoto; T Fujita
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Multiple factors involved in the control of ACTH secretion.

Authors:  L Proulx; V Giguère; J Côté; F Labrie
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

4.  Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.

Authors:  A J Hadley; M Kumari; P O Cover; J Osborne; R Poyser; J D Flack; J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

Authors:  D N Orth; R V Jackson; G S DeCherney; C R DeBold; A N Alexander; D P Island; J Rivier; C Rivier; J Spiess; W Vale
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

6.  Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Authors:  Ning-Ai Liu; Takako Araki; Daniel Cuevas-Ramos; Jiang Hong; Anat Ben-Shlomo; Yukiko Tone; Masahide Tone; Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

7.  Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway.

Authors:  Sang Hoon Rhee; Elise L Ma; Yunna Lee; Yvette Taché; Charalabos Pothoulakis; Eunok Im
Journal:  J Biol Chem       Date:  2015-09-08       Impact factor: 5.157

8.  Mechanism underlying corticotropin-releasing hormone (CRH) triggered cytosolic Ca2+ rise in identified rat corticotrophs.

Authors:  A K Lee; A Tse
Journal:  J Physiol       Date:  1997-10-15       Impact factor: 5.182

9.  Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells.

Authors:  A Luini; D Lewis; S Guild; D Corda; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

Authors:  Juliette Rambaud; Julien Desroches; Aurélio Balsalobre; Jacques Drouin
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.